Unlike researchers, for hands on doctors like you, I am not sure if exclusive focus either on the host or the virus is possible in your daily practice. They are one and the same, even in the second phase where the virus takes the backseat in controlling the disease. The repurposed anti virals can work with two clear focuses. Example, an …
Unlike researchers, for hands on doctors like you, I am not sure if exclusive focus either on the host or the virus is possible in your daily practice. They are one and the same, even in the second phase where the virus takes the backseat in controlling the disease. The repurposed anti virals can work with two clear focuses. Example, an anti histamine will mitigate the histamine release based symptoms of the host. Its repurposed anti viral property will directly work on the virus stopping the load build up. All these considerations are now history, as with Omicrons the second phase is absent. But its milder viral phase ( only phase) cannot be ignored from early URT treatments, unlike similar looking common cold. How have handled it in the last 2 years ? I cannot still figure out why the Omicrons have continued to roil the USA with deaths, about 4000 plus per month even now. Even with the continuing shunning of early treatment protocols, even with the claims it is all people with predispositions ( which I do not accept), this phenomenon of mortality is unprecedented and unacceptable. Any thoughts ? Are you able to exclude Omicron based mortality in your cases. You know very well how Omicron is totally out of currency in many parts of the world, including India, for two years now.
The cases reported across india are highly insignificant to cause any alarm. Moreover strain specific testing is not at all a common practice. The new normal of excess mortality and life disabling/ threatening morbidities being reported across the highly vaccinated populations deserves critical investigation. From the beginning i was never convinced with mRNA approach to vaccination
Unlike researchers, for hands on doctors like you, I am not sure if exclusive focus either on the host or the virus is possible in your daily practice. They are one and the same, even in the second phase where the virus takes the backseat in controlling the disease. The repurposed anti virals can work with two clear focuses. Example, an anti histamine will mitigate the histamine release based symptoms of the host. Its repurposed anti viral property will directly work on the virus stopping the load build up. All these considerations are now history, as with Omicrons the second phase is absent. But its milder viral phase ( only phase) cannot be ignored from early URT treatments, unlike similar looking common cold. How have handled it in the last 2 years ? I cannot still figure out why the Omicrons have continued to roil the USA with deaths, about 4000 plus per month even now. Even with the continuing shunning of early treatment protocols, even with the claims it is all people with predispositions ( which I do not accept), this phenomenon of mortality is unprecedented and unacceptable. Any thoughts ? Are you able to exclude Omicron based mortality in your cases. You know very well how Omicron is totally out of currency in many parts of the world, including India, for two years now.
The cases reported across india are highly insignificant to cause any alarm. Moreover strain specific testing is not at all a common practice. The new normal of excess mortality and life disabling/ threatening morbidities being reported across the highly vaccinated populations deserves critical investigation. From the beginning i was never convinced with mRNA approach to vaccination